Search Within

Peter Smith-Jones

Formats
  1. Journal Article (42)
  2. Meeting Abstract (24)
  3. Book Section (1)
Groups
  1. GSK Faculty (57)
  2. Radiology, Department of (55)
  3. Molecular Pharmacology and Chemistry Program Faculty (53)
  4. Sloan Kettering Institute Faculty (53)
  5. Molecular Imaging and Therapy Service (52)
  6. Medical Physics (36)

More Groups

People
  1. Steven Larson (51)
  2. Pat Zanzonico (25)
  3. Neeta Pandit-Taskar (21)
  4. John Humm (18)
  5. Jorge Carrasquillo (14)
  6. Joseph O'Donoghue (13)

More People

Years
  1. 2019 (1)
  2. 2018 (1)
  3. 2017 (1)
  4. 2016 (1)
  5. 2015 (1)
  6. 2014 (1)

More Years

Publications
  1. Journal of Nuclear Medicine (13)
  2. Cancer Research (6)
  3. European Journal of Nuclear Medicine and Molecular Imaging (4)
  4. Neuro-Oncology (4)
  5. Pediatric Blood and Cancer (3)
  6. Clinical Cancer Research (2)

More Publications

Publishers
  1. Society of Nuclear Medicine (13)
  2. American Association for Cancer Research (9)
  3. Springer (9)
  4. Oxford University Press (4)
  5. Elsevier Inc. (3)
  6. Elsevier Science, Inc. (3)

More Publishers

Results (67)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I trial to evaluate J591 as a vascular targeting agent in patients with advanced solid tumors
    Meeting Abstract

    Morris, M. J.; Divgi, C.; Kelly, W. K.; Slovin, S.; Solit, D.; Shaffer, D.; Halpern, J.; Delacruz, A.; Curley, T.; Nacca, A.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • Rapid MicroPET imaging of 17AAG induced HER2 protein downregulation using Ga-68-DOTA-F(ab ')(2) herceptin
    Meeting Abstract

    Smith-Jones, P. M.; Solit, D.; Afroze, F.; Akhurst, T.; Rosen, N.; Larson, S. M.
    Journal of Nuclear Medicine (2003)

    Fulltext@MSK | Save
  • Ga-68 labelling of Annexin-V: Comparison to 99-Tc-Annexin-V and Ga-67-Annexin
    Meeting Abstract

    Smith-Jones, P. M.; Afroze, A.; Zanzonico, P.; Tait, J.; Larson, S. M.; Strauss, H. W.
    Journal of Nuclear Medicine (2003)

    Fulltext@MSK | Save
  • Optimization of biodistribution parameters for radioimmunotherapy: Clinical trial with HuJ591
    Meeting Abstract

    Pandit-Taskar, N.; Morris, M. J.; Batraki, M.; Perez, A.; Nacca, A.; Smith-Jones, P.; Halpern, J.; Finn, R.; Scher, H. I.; Bander, N. H.; more...
    Journal of Nuclear Medicine (2003)

    Fulltext@MSK | Save
  • Tumor localization of [18F]-Fluoro-Dihydro-testosterone (FDHT) versus [18F]-2-Fluoro-D-glucose (FDG) in patients with progressive, metastatic prostate cancer
    Meeting Abstract

    Larson, S. M.; Gunther, I.; Morris, M.; Beattie, B.; Akhurst, T. A.; Finn, R.; Pentlow, K.; Zanzonico, P.; Erdi, Y.; Humm, J.; more...
    Journal of Nuclear Medicine (2003)

    Fulltext@MSK | Save
  • Localization of pancreatic tumors with CC49 single-chain antibody-streptavidin fusion protein (CC49-SA) in a multi-step-targeting (MST) approach
    Meeting Abstract

    Forster, G. J.; Santos, E. B.; Smith-Jones, P. M.; Zanzonico, P.; Axworthy, D.; Theodore, L. J.; Larson, S. M.
    Journal of Nuclear Medicine (2003)

    Fulltext@MSK | Save
  • Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen
    Journal Article

    Bander, N. H.; Trabulsi, E. J.; Kostakoglu, L.; Yao, D.; Vallabhajosula, S.; Smith-Jones, P.; Joyce, M. A.; Milowsky, M.; Nanus, D. M.; Goldsmith, S. J.
    Journal of Urology (2003)

    Fulltext@MSK | Save